Orchestra BioMed Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	18.35	22.26	30.56	19.78	9.94	20.34
Short-Term Investments	31.54	44.55	57.04	64	0.96	15.45
Cash & Short-Term Investments	49.88	66.81	87.6	83.79	10.9	35.79
Cash Growth	-33.52%	-23.73%	4.55%	668.95%	-69.56%	-
Receivables	0.09	0.09	0.1	0.1	0.12	0.17
Inventory	0.14	0.17	0.15	0.28	0.07	0.07
Prepaid Expenses	1.8	2.09	1.27	0.53	0.23	0.23
Total Current Assets	51.9	69.17	89.11	84.69	11.32	36.25
Property, Plant & Equipment	3.37	3.49	2.83	3.68	1.12	1.03
Long-Term Investments	2.5	2.5	2.5	2.5	0.4	0.19
Long-Term Deferred Charges	-	-	-	4	0.1	-
Other Long-Term Assets	1.28	1.02	0.77	0.71	0.59	0.63
Total Assets	59.05	76.17	95.21	95.57	13.53	38.09
Accounts Payable	5.56	5.13	2.9	3.97	2.03	1.77
Accrued Expenses	5.39	6.08	5.15	5.38	1.89	1.41
Current Portion of Long-Term Debt	-	-	-	-	2	4
Current Portion of Leases	0.59	0.55	0.65	0.7	-	-
Current Unearned Revenue	3.94	4.44	2.51	6.44	5.54	5.8
Other Current Liabilities	-	-	-	2.09	0.78	1.38
Total Current Liabilities	15.49	16.21	11.21	18.57	12.24	14.36
Long-Term Debt	14.34	14.29	-	9.49	3.67	5.46
Long-Term Leases	1.52	1.69	1.04	1.68	-	-
Long-Term Unearned Revenue	10.75	10.99	14.92	13.1	16.86	15.12
Other Long-Term Liabilities	0.1	0.04	-	0.2	0.54	0.24
Total Liabilities	42.19	43.22	27.17	43.04	33.31	35.18
Common Stock	0	0	0	0	-	-
Additional Paid-In Capital	345.45	342.78	316.9	252.27	94.89	94.57
Retained Earnings	-328.63	-309.88	-248.85	-199.73	-166.13	-143.11
Comprehensive Income & Other	0.04	0.05	-0.01	-0.01	-	-0
Total Common Equity	16.86	32.96	68.04	52.53	-71.23	-48.54
Shareholders' Equity	16.86	32.96	68.04	52.53	-19.78	2.91
Total Liabilities & Equity	59.05	76.17	95.21	95.57	13.53	38.09
Total Debt	16.44	16.53	1.69	11.87	5.67	9.46
Net Cash (Debt)	33.44	50.28	85.91	71.92	5.22	26.33
Net Cash Growth	-54.45%	-41.47%	19.46%	1276.89%	-80.17%	-
Net Cash Per Share	0.89	1.37	2.59	4.80	2.47	13.08
Filing Date Shares Outstanding	38.31	38.31	35.78	2.52	2.19	2.01
Total Common Shares Outstanding	38.31	38.19	35.78	2.52	2.19	2.01
Working Capital	36.41	52.96	77.91	66.12	-0.92	21.89
Book Value Per Share	0.44	0.86	1.90	20.83	-32.60	-24.11
Tangible Book Value	16.86	32.96	68.04	52.53	-71.23	-48.54
Tangible Book Value Per Share	0.44	0.86	1.90	20.83	-32.60	-24.11
Machinery	2.64	2.53	2.12	2.08	1.51	1.24
Construction In Progress	-	-	-	-	0.02	0.04
Leasehold Improvements	0.16	0.16	0.2	0.19	0.18	0.17

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q